The time course of the plasma lignocaine concentration, following caudal anaesthesia, was studied in 11 healthy children (3.5-9yr). Plasma lignocaine concentrations were measured for up to 6h after administration (Smgkg" 1 )-Peak plasma concentration was 2.05 + 0.08 fig ml" 1 and occurred at 28.2±2.9min after administration. Pharmacokinetic parameters determined from a two-compartmental model were «imilar to those observed after the i. v. or extradural administration of lignocaine in adults, except for a longer half-life of diminution (155±32min). Since the total body clearance of lignocaine was similar in children (15.4± 1.2mlmin"'kg" 1 ) to that in adults, the longer half-life of elimination was attributed to a larger volume of distribution in the children (3.05 ±0.40 litre kg" 1 ).
Although caudal anaesthesia is used widely in children (Fortuna, 1967; Schulte-Steinberg and Rahlfs, 1970; Armitage, 1979) , few studies have considered the pharmacokinetic analysis of the local anaesthetic drugs administered by this route. To date, the only available data relate to mean plasma concentrations following the caudal injection of lignocaine and bupivacaine (Eyres et al., 1978) . The present study determined the time course of the plasma concentrations of lignocaine, its initial vascular absorption rate and its elimination characteristics following caudal anaesthesia in healthy children.
PATIENTS AND METHODS
Eleven children (six boys) aged 5.3±0.5yr, weighing 19.5 ± 1.8 kg were studied. They were free of cardiac, renal or hepatic disease, and were about to undergo lower abdominal or genito-urinary surgery. The study was approved by the Human Investigation Committee and parental consent was obtained. All patients had fasted for 6h before anaesthesia and were premedicated with atropine 0.02 mgkg" 1 and diazepam0.3mgkg" 1 i.m. lh before surgery. Heart rate was recorded continuously from the electrocardiogram and arterial pressure measured by standard sphygmomanometry every 5 min. Anaesthesia was induced by the inhalation of 70% nitrous oxide plus 1% halothane in oxygen using a partial rebreathing system while patients were lying on their side. Halothane was inhaled for a short period which was always less than 10 min. Once the lid reflex had disappeared, a 22-gauge needle was inserted to the caudal extradural space, and the halothane discontinued. One percent lignocaine 5 ing kg" 1 (98.4 ± 9.4 mg) was injected at a rate of about lmls" 1 . Venous blood samples (0.5 ml) were drawn from a cannula placed in an antecubital vein. Samples were collected before and 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 60, 90, 120, 240 and 360 min after the end of the injection of lignocaine. Plasma was separated by centrifugation at 4°C and stored at -20°C for further analysis. Plasma lignocaine concentrations were assayed in duplicate by the specific EMIT homogenous enzyme immunoassay (Syva Biomerieux Laboratories), which measured the concentration of lignocaine between 1 and 12 ng ml" 1 with a coefficient of variation of less than 10%. Studies in our laboratory showed no cross reactivity between lignocaine and its two major metabolites, monoethylglycinxylidide and glycinxylidide. The pharmacokinetic parameters of lignocaine following caudal anaesthesia were calculated using a twocompartment open model. For each child the lignocaine concentration v. time data were fitted by the non-linear least-squares method using an iterative GRAPHAKIN program. A Tektronix 4052 computer was used in the calculations. Pharmacokinetic parameters were calculated as maximum concentration (Q nj, time to Q, "" (O. vascular absorption and elimination half-lives (Tj* 1 " and Tf), volume of distribution ( V), total body clearance (CJ°*), and the area under the plasma concentration-time curve extrapolated from zero time to infinity according to the trapezoidal rule.
RESULTS
Neither heart rate nor arterial pressure were affected by the institution of caudal anaesthesia. Figure 1 shows the mean time course of the plasma lignocaine concentration following caudal anaesthesia and table I summarizes individual pharmacokinetic parameters. After the injection of lignocaine, the mnvimiiTn concentration of the drug in the plasma was achieved between 15 and 40min (tm = 28.2 ±2.9 min) and the concentration ranged from 1.6 to 2.5ngml" 1 (Q M = 2.05 ±0.08 figml" 1 )-The half-life of vascular absorption was 8.9±1.0min (Tf*) (**» = 0.09±0.01) and the half-life of the elimination phase was 155 ± 32 min. The total plasma clearance of lignocaine was 15.4 ±1.2 mlmin" 1 kg" 1 (C/,) and V was 3.05 ± 0.40 litre kg" 1 ). The area under the plasma concentration-time curve (AUC) was 347 ±27
DISCUSSION
The present results confirm the views expressed previously (Fortuna, 1967; Schulte Steinberg and Rahlfs, 1970 ) that caudal anaesthesia with lignocaine is an effective and safe technique in children since no adverse cardiovascular or central nervous effects were observed. Cpma was similar to that reported previously (Eyres et al., 1978) in children following caudal injection of 1% lignocaine 4mgkg" 1 and by Freund and colleagues (1982) adults following the caudal injection of 2% lignocaine 6mgkg-1 with adrenaline 1:200000; 0-ŵ as well below the value of 5 ngml" 1 considered as toxic in adults (Foldes et al., 1960) . According to Eyres and colleagues (1978) , the short initial halflife of vascular absorption of lignocaine (T)***) confirms that this local anaesthetic drug is absorbed rapidly through the caudal extradural space in children. However, the half-life of elimination (Tj') of lignocaine after caudal administration was slightly longer than the corresponding values reported in adults following the i.v. (Benowitz and Meister, 1978) or extradural injection of lignocaine (Tucker and Mather, 1975) . Although this pharmacokinetic parameter has not been reported previously in chil- dren, it might be interpreted as the result of either a decrease in the rate of elimination of lignocaine, or the larger volume of distribution in children compared with adults. Since the total body clearance (Cl m ) of lignocaine in the present study was of the same magnitude as that in adults following an i.v. (Benowitz and Meister, 1978) or an extradural injection (Tucker and Mather, 1975) , a major decrease in the rate of elimination of lignocaine through a decrease in its predominant hepatic metabolism by residual halothane anaesthesia can be almost totally excluded (Epstein et al., 1966) . Above all, a larger volume of distribution of lignocaine in children, compared with adults, can be suggested as an explanation for the longer half-life of elimination value since V is up to three times larger in the present study in children than in previous Vvalues reported in adults (Tucker and Mather, 1975) , and since Tf is linked closely to V by the formula: 7V= 0.693 x V/CT" (Morischima et al., 1979 ).
In conclusion, pharmacokinetic parameters of lignocaine after caudal anaesthesia in children were similar to those reported after the injection of lignocaine in adults, except for Tj", which was slightly longer. -9anos) , $e estudkSel cursode ticmpo de las concenu acioneg de lignocaina en el plasma despues de una anestesia caudal. Se midieron las concentracionet de lignocaina en d plasma durante hasta 6h despues de la administracion (5mgkg~*). La concentraci6n m^-rima en d plasma era de 2,05 ± 0,08 ng ml" 1 y ocurrio a los 28^ ± 2,9 min despues de la administraci6n. Los panunetros farmacocdncticos detenninados mediante un modelo dc dos compartimientos eran similarcs a los observados despues de la administracion i.v. o extr&dural en aduhos, salvo en lo que se refiere a la mayor media-vida dê liTninor^An (155 i 32 min). Puesto que la Miminarifm corporal total de la lignocaina era «imi1flr en los ninos (15,4±l,2mlmin kg~')y en los adultos, se atribuyd la mayor media-vida de ^ltminat»ffip a un mayor volumcn de distribucion en los nifiog (3,05 ± 0,40 litro kg"').
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